Skip to content

Medical emergency? What to do

Developing New Treatments for Triple-Negative Breast Cancer

3-RXPublished April 3, 20091 min read

Key points

  • Brian Rowan, Ph.D., professor of Cancer Research for the Tulane Cancer Center, is studying treatment options for an aggressive type of breast cancer that is prevalent in New Orleans among African-American women—triple-negative breast cancer.
  • “KX-01 in combination with chemotherapy kills even more cancer cells,” said Rowan.
  • Rowan is available to talk about the prevalence of triple-negative breast cancer and the future of drug treatments to stop its progression.
  • Rowan is studying a therapy that targets a protein called Src kinase, which is required for tumor growth in triple negative breast cancer.

Brian Rowan, Ph.D., professor of Cancer Research for the Tulane Cancer Center, is studying treatment options for an aggressive type of breast cancer that is prevalent in New Orleans among African-American women—triple-negative breast cancer. The term triple-negative refers to the fact that these tumors do not have estrogen, progesterone or HER2 receptors, effectively eliminating hormonal and targeted herceptin therapy from the list of possible treatment options. This limits therapeutic choices for these patients to surgery, radiation and chemotherapy.

Rowan is studying a therapy that targets a protein called Src kinase, which is required for tumor growth in triple negative breast cancer. Rowan and his team are working with Kinex Pharmaceuticals in Buffalo, N.Y. to test a new Src inhibitor called KX-01. Phase I trials for this new drug are complete and preliminary results indicate that KX-01 kills triple-negative breast cancer cells in both Petri dishes and in animal tumor models.

“KX-01 in combination with chemotherapy kills even more cancer cells,” said Rowan.

He hopes to begin Phase II trials for KX-01 alone or in combination with chemotherapy for triple-negative breast cancer patients here in New Orleans by 2010.

Rowan is available to talk about the prevalence of triple-negative breast cancer and the future of drug treatments to stop its progression. He is also an expert in understanding the roles of nuclear receptors—estrogen, progesterone, and HER2— in breast cancer treatment, and understanding the role of mesenchymal stem cells in breast cancer metastasis to the bone.

Source: Tulane University

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.